Please check your internet connection and try again.
# Montelukast/Levocetirizine
## Overview
Montelukast is a leukotriene receptor antagonist. Levocetirizine is a second-generation antihistamine. This combination is used for the treatment of allergic rhinitis and chronic urticaria.
## Primary Indications
* Allergic rhinitis (seasonal and perennial)
* Chronic idiopathic urticaria
## Adult Dosing
* **Allergic Rhinitis:** Montelukast 10 mg orally once daily plus levocetirizine 5 mg orally once daily.
* **Chronic Urticaria:** Montelukast 10 mg orally once daily plus levocetirizine 5 mg orally once daily.
The maximum daily dose for montelukast is 10 mg. The maximum daily dose for levocetirizine is 5 mg.
## Pediatric Dosing
Dosing for the combination product in pediatrics is weight-based and age-dependent.
* **Children 6 to 11 months:** Montelukast 4 mg orally once daily; levocetirizine is not typically recommended in this age group due to limited data.
* **Children 1 to 5 years:** Montelukast 4 mg orally once daily plus levocetirizine 1.25 mg orally once daily.
* **Children 6 to 14 years:** Montelukast 5 mg orally once daily plus levocetirizine 2.5 mg orally once daily.
* **Adolescents 15 years and older:** Montelukast 10 mg orally once daily plus levocetirizine 5 mg orally once daily.
Consult specific pediatric guidelines or the product monograph for precise dosing.
## Dose Adjustments
* **Renal Impairment:** No dose adjustment necessary for montelukast. For levocetirizine, dose reduction may be necessary in moderate to severe renal impairment. Consult product labeling for specific recommendations.
* **Hepatic Impairment:** No dose adjustment necessary for montelukast. For levocetirizine, dose reduction may be necessary in moderate to severe hepatic impairment. Consult product labeling for specific recommendations.
## Contraindications
* Hypersensitivity to montelukast, levocetirizine, or any component of the formulation.
* Severe renal impairment (for levocetirizine component).
## Adverse Effects
Common adverse effects include somnolence, fatigue, headache, dizziness, and dry mouth. Neuropsychiatric events have been reported with montelukast, including agitation, aggression, depression, and suicidal ideation.
## Key Drug Interactions
* **CYP1A2 Inhibitors/Inducers:** Montelukast is metabolized by CYP1A2, though interactions are generally not clinically significant.
* **CNS Depressants:** Levocetirizine can potentiate the effects of alcohol and other CNS depressants, leading to increased drowsiness.
* **Theophylline:** Montelukast may increase theophylline levels; monitor theophylline levels if coadministered.
## Monitoring
* Monitor for neuropsychiatric symptoms with montelukast, especially in patients with a history of psychiatric disorders.
* Monitor for sedation and cognitive impairment with levocetirizine, especially when combined with other sedating agents.
* Assess effectiveness in improving allergy or urticaria symptoms.
## Clinical Pearls
* Montelukast/levocetirizine provides a dual mechanism of action for allergic rhinitis and urticaria.
* Administer montelukast in the evening, regardless of mealtime.
* Levocetirizine can cause significant drowsiness; advise caution with driving or operating heavy machinery.
* The risk of neuropsychiatric events with montelukast warrants careful patient counseling.
***
*Please verify the current prescribing information for the most up-to-date details on dosing, indications, contraindications, and adverse effects.*
